AlveoliX raises funding

AlveoliX develops organ-on-chip platforms that mimic human organs in vitro. It is part of a European consortium that has received a total of EUR 1 million in Eurostars funding to develop Nexopore, a technique for delivering nucleic acid therapies.

Announced on
Round
Grant
Amount
Amount not disclosed
Location
Bern
Sector
Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic